Depression and Smoking Cessation: Evidence from a Smoking Cessation Clinic with 1-Year Follow-Up
Open accessThe DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index; 14 of the 28 sources its claims cite were checked for support.
Abstract
Smoking is more prevalent among people with depression. Depression may make cessation more difficult and cessation may affect depression symptoms. The aims of this study were to assess the associations between (1) baseline depression and 1-year smoking abstinence and (2) abstinence and change in depression. Observational study using data collected routinely in a smoking cessation clinic in the Czech Republic from 2008 to 2014. Aim 1: N = 3775 patients; 14.3% reported mild and 15.4% moderate/severe baseline depression levels measured using Beck's Depression Inventory (BDI-II). Logistic regressions assessed if depression level predicted 1-year biochemically verified abstinence while adjusting for patient and treatment characteristics. Aim 2: N = 835 patients abstinent at 1 year; change in depression was analysed using Chi-square statistics, t test and mixed method analyses of variance. Rate of abstinence was lower for patients with mild (32.5%, OR = 0.68; 95% CI: 0.54 to 0.87, p = 0.002) and moderate/severe depression (25.8%; OR = 0.57, 95% CI: 0.45 to 0.74, p < 0.001) compared with patients without depression (40.5%). Across abstinent patients, the majority with baseline depression reported lower depression levels at follow-up. Overall mean (SD) BDI-II scores improved from 9.2 (8.6) to 5.3 (6.1); t(834) = 14.6, p < 0.001. There were significant main effects of time (F(1832) = 880.8, p < 0.001, partial η2 = 0.51) and baseline depression level (F(2832) = 666.4, p < 0.001, partial η2 = 0.62) on follow-up depression and a significant depression * time interaction (F(2832) = 296.5, p < 0.001, partial η2 = 0.42). In this effective smoking cessation clinic, depression at the start of treatment predicted reduced smoking abstinence 1 year later. Patients abstinent from smoking experienced considerable improvement in depression.
Overview
CoChat Summary
TL;DR
In a Czech smoking cessation clinic, baseline depression predicted lower 1-year biochemically verified abstinence, and patients abstinent at 1 year showed substantial improvement in depression. The observational design could not compare depression change in those who continued smoking.
Key findings
- Overall CO-verified 1-year abstinence was 37.1%. Compared with no/minimal depression (40.5% abstinent), mild baseline depression was associated with lower abstinence (32.5%; adjusted OR = 0.68, 95% CI 0.54–0.87, p = 0.002) and moderate/severe depression with lower abstinence (25.8%; adjusted OR = 0.57, 95% CI 0.45–0.74, p < 0.001).
- Among 835 abstinent patients with baseline and follow-up BDI-II, mean (SD) depression improved from 9.2 (8.6) to 5.3 (6.1); t(834) = 14.6, p < 0.001. Mixed-model ANOVA showed main effects of time (F(1,832) = 880.8, p < 0.001, partial η² = 0.51), baseline depression level (F(2,832) = 666.4, p < 0.001, partial η² = 0.62), and depression × time interaction (F(2,832) = 296.5, p < 0.001, partial η² = 0.42).
- Median BDI-II decreased from 5 to 3 for no/minimal, 16 to 7 for mild, and 25 to 10 for moderate/severe baseline depression (all p < 0.001). Baseline antidepressant use was marginally associated with lower abstinence (32.9% vs 37.7%; OR = 0.81, 95% CI 0.65–0.999, p = 0.049; adjusted OR = 0.79, 95% CI 0.62–1.01, p = 0.061).
- Number of visits was a strong predictor: in the primary model, 5 or more visits had OR = 9.57 (95% CI 7.59–12.08, p < 0.001) versus fewer than 3; in the model including length of pharmacotherapy, OR = 5.91 (95% CI 4.47–7.83, p < 0.001).
Methods
- Observational study using routinely collected data from the Center for Tobacco Dependence, General University Hospital, Prague, Czech Republic, 2008–2014. Treatment was face-to-face counselling plus a choice of pharmacotherapy; it did not include specific treatment for depression or other mental health problems.
- Aim 1: logistic regressions of 1-year biochemically verified abstinence (Russell Standard: self-reported ≤5 cigarettes since quit date and exhaled CO <10 ppm; lost to follow-up counted as not abstinent) on baseline BDI-II category (none/minimal ≤13, mild 14–19, moderate/severe ≥20), adjusted for age, gender, education, marital status, FTND dependence, other mental health problems, number of visits, and pharmacotherapy type. Primary model N = 3380 (abstract states N = 3775); additional model including length of pharmacotherapy N = 2545.
- Aim 2: among patients abstinent at 1 year with baseline and follow-up BDI-II (N = 835), change in depression was analysed with chi-square statistics, paired t test, and mixed-model ANOVA; also examined by baseline depression level and pharmacotherapy.
Limitations
- The paper states: all patients were outpatients, potentially limiting generalisability to patients ill enough to be hospitalised; depression at follow-up was generally not recorded for non-abstainers, so changes could not be compared between abstinent and non-abstinent patients; only two time points were available, so the direction of the association cannot be determined.
- The paper states/acknowledges: observational routine-clinic data with no randomised control group; other mental health problems were self-reported and combined because frequencies were low; reverse causality for visit attendance is possible, since successful patients may be more likely to attend subsequent visits.
- Evident from the text: the abstract reports N = 3775 for Aim 1 while the methods and Table 1 report N = 3380, and this discrepancy is not explained; counting lost-to-follow-up patients as not abstinent may bias abstinence rates downward.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
10 Valid · 1 Not valid · 7 Not checked · 43 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“there is evidence across all ages that the negative effect of depression on cessation is stronger for women [16, 17].”
§ Depression and Smoking Cessation: Evidence from a Smoking Cessation Clinic with 1-Year Follow-Up > Introduction
What the sources say
- Partly supportedcites [16] Weinberger AH, Mazure CM, Morlett A, McKee SA: Two decades of smoking cessation treatment research on smokers with depression: 1990-2010. Nicotine Tob Res. 2013; 15:1014–1031. sourceExperimental — accuracy not yet measured
The Discussion of Weinberger et al. (2013) states that "the majority of studies in this review that considered gender reported that depression had a greater negative impact on smoking cessation outcomes for women as compared with men," and the Abstract and "Gender and the Analyses of Depression and Smoking Cessation Outcomes" section repeat this, so the core of the claim is supported. However, nothing in our copy supports the age qualifier "across all ages": the review's "Mean Age of Participants" section reports 49 studies with mean sample ages ranging 16–59 years and three-quarters between 40 and 49, with no age-stratified evidence on the depression–cessation gender interaction. Our copy also tempers the generality — two of the seven studies examining gender differences found none (Japuntich et al., 2007; Kinnunen et al., 2008), and the authors' own epidemiological analyses found cessation rates similarly impacted by depression for men and women in the general U.S. adult population. (LLM, conf=0.78)
- Misattributedcites [17] Cooper J, Borland R, McKee SA, Yong HH, Dugue PA: Depression motivates quit attempts but predicts relapse: differential findings for gender from the International Tobacco Control Study. Addiction. 2016; 111(8):1448-56. doi: 10.1111/add.13367 sourceExperimental — accuracy not yet measured
Our copy of Cooper et al. (2016) reports no gender difference in its own results: the moderators it reports are T1 depressive symptoms, age and HSI (Results; Abstract Findings), and although gender was among the variables tested for interaction (Method, Analysis plan), no sex-differential result appears. The Discussion instead credits the point to another work: 'the finding in our companion paper that those with depression were more likely to make quit attempts [31] ... However, the finding that depression predicts increased relapse [31,32] cannot be accounted for by such a mechanism.' Reference 31 is Cooper, Borland & McKee, 'Depression motivates quit attempts but predicts relapse: Differential findings for gender from the International Tobacco Control Study' (10.1111/add.13290), which is where the gender differential — and hence 'stronger for women' — belongs; the 'across all ages' element is contrary to this paper's own age-stratified findings but is not stated here as a result. (LLM, conf=0.74) It matches “Depression motivates quit attempts but predicts relapse: Differential findings for gender from the International Tobacco Control Study” instead.
Checked by a reasoning model — may be wrong.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Smoking is more prevalent among people with depression.”
- Also stated in: § Introduction · plain
“among people with depression, smoking prevalence is about twice as high as in the general population [1–3]”
§ Depression and Smoking Cessation: Evidence from a Smoking Cessation Clinic with 1-Year Follow-Up > Abstract > Background
What the sources say
- Not checked yetcites [1] Royal College of Physicians, Royal College of Psychiatrists: smoking and mental health. London: RCP, 2013.
- Supportedcites [2] Smith PH, Mazure CM, McKee SA: Smoking and mental illness in the US population. Tob Control. 2014; 23(e2):e147–e153. doi: 10.1136/tobaccocontrol-2013-051466 source
The cited sentence attributes to Smith et al. (2014) only the directional claim that smoking is more prevalent among people with depression. Our copy states this directly: RESULTS ('Prevalence of smoking among those specific lifetime or past year psychiatric diagnoses') reports that 'All past year diagnoses were associated with higher smoking prevalence and lower quit rates than those with no psychiatric disorders (p < 0.001)' (Tables 3-4), and the DISCUSSION/Abstract give 39.0% current smoking for past-year diagnoses versus 15.5% for no diagnosis, with per-diagnosis prevalence ranging 32.4%-66.7%. Mood-disorder diagnoses (including major depressive episode and dysthymia) are treated throughout as part of these elevated-prevalence groups; the paper's own figures exceed a two-fold difference, so the citing sentence's weaker wording is supported. Note the source compares against those with no psychiatric diagnosis rather than an unselected 'general population', and the depression-specific figure sits in Tables 3-4 rather than the narrative text. (LLM, conf=0.88)
- Supportedcites [3] Lawrence D, Mitrou F, Zubrick SR: Smoking and mental illness: results from population surveys in Australia and the United States. BMC Public Health. 2009; 9:285. source
The Results sections and Tables 1–2 of Lawrence et al. (2009) give disorder-specific smoking rates that state the claim: US 'Depressive episode' 41.3% current smokers (Table 2) and Australian 'Depressive episode' 38.4% (Table 1), against 21.3% (US) and 18.8% (Australia) among adults with no 12-month mental disorder — i.e. roughly double. The Results text (Mental illness and smoking in non-institutionalised adults in the US) explicitly contrasts 45.1% of adults with affective disorders with 21.3% of those with no 12-month mental disorder, and the Abstract reports adults with mental disorders smoking 'at almost twice the rate' of those without. The only nuance is that the paper's reference group is adults without mental disorder rather than the whole general population, but the magnitude attributed ('about twice') matches its reported figures. (LLM, conf=0.85)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Introduction · plain
Every source the paper cites for this claim was checked and supports it.
In the paper
“In older smokers (not all of whom were attempting to quit), level of depression predicted continued smoking [11]”
§ Depression and Smoking Cessation: Evidence from a Smoking Cessation Clinic with 1-Year Follow-Up > Introduction
What the sources say
- Supportedcites [11] Shahab L, Gilchrist G, Hagger-Johnson G, et al.: Reciprocal associations between smoking cessation and depression in older smokers: findings from the English longitudinal study of ageing. Br J Psychiatry. 2015; 207:243–249. source
The Results report that greater cumulative exposure to depression was associated with a higher likelihood of remaining a smoker at follow-up. The Discussion states that depression predicted continued smoking among older adults and notes that the study had no information about quit attempts, consistent with the citing sentence’s qualification. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“a recent systematic review and meta-analysis of longitudinal studies found that compared with continuing to smoke, quitting smoking was associated with a significant decrease in depression from baseline to follow-up [9]”
- Also stated in: § Introduction · hedged
“This is corroborated by recent findings from smoking cessation practice indicating continuous improvements in depression symptoms over 1 year among those who quit smoking and no change in those who continued to smoke [10].”
§ Depression and Smoking Cessation: Evidence from a Smoking Cessation Clinic with 1-Year Follow-Up > Introduction
What the sources say
- Supportedcites [9] Taylor G, McNeill A, Girling A, et al.: Change in mental health after smoking cessation: systematic review and meta-analysis. Bmj. 2014; 348:g1151. source
The Abstract (Results) of our copy states that 'Anxiety, depression, mixed anxiety and depression, and stress significantly decreased between baseline and follow-up in quitters compared with continuing smokers,' with depression SMD -0.25 (95% CI -0.37 to -0.12), and the design is described as a systematic review and meta-analysis of longitudinal (RCT and cohort) studies of adults. The Abstract Conclusion and the Discussion ('stopping smoking is associated with improvements in depression... compared with continuing to smoke') restate the same point, matching every element the citing sentence attributes: comparison with continuing smoking, change from baseline to follow-up, and significance for depression. (LLM, conf=0.92)
- Not checked yetcites [10] Rodriguez-Cano R, Lopez-Duran A, Del Rio EF, et al.: Smoking cessation and depressive symptoms at 1-, 3-, 6-, and 12-months follow-up. J Affect Disord. 2016; 191:94–99. source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Introduction · hedged
Every source the paper cites for this claim was checked and supports it.
In the paper
“In an earlier sample from the clinic used in the present study, a history of depression was not associated with abstinence [24]”
§ Depression and Smoking Cessation: Evidence from a Smoking Cessation Clinic with 1-Year Follow-Up > Discussion
What the sources say
- Supportedcites [24] Stepankova L, Kralikova E, Zvolska K, et al.: Tobacco treatment outcomes in patients with and without a history of depression, Czech Republic, 2005-2010. Prev Chronic Dis. 2013; 10:E158. source
Our copy is a clinic-based sample from the Center for Tobacco-Dependence at General University Hospital, Prague (2005–2010; 1,730 smokers; Methods > Treatment program), i.e. an earlier sample from that clinic, and its central finding is the null association: 'After adjustment for baseline covariates, history of depression was not significantly associated with smoking abstinence in men or women' (Abstract > Results; repeated in Discussion). The caveat worth carrying over is that this null is the adjusted result — unadjusted, abstinence was lower in the depression group overall (32.5% vs 38.7%, P = .048) and significantly so in men (27.4% vs 41.3%, P = .009) — but the citing sentence's attributed point (no association of history of depression with abstinence) is what the paper concludes. (LLM, conf=0.82)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
31 more claims · 4 with their cited sources checked
Create a free account to see all 61 claims and to verify the 14 references still open.
- Probably not a substantial claim. 14
- It may state two separate claims as one. 13
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These five core processes have predicted smoking frequency,33,34,36 cessation,33,35,36 and relapse in cancer patients.35”
From Efficacy of smartphone applications to help cancer patients quit smoking: Protocol of the Quit2Heal randomized controlled trial (2023) · cites this paper as [35]
Experimental — accuracy not yet measured
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- Consistentt(834) = 14.6reported p < .001 · recomputed p < .001
“t(834) = 14.6, p < .001”
- Consistentz = -14.1reported p < .001 · recomputed p < .001
“Z = −14.1, p < .001”
- Consistentz = -12.9reported p < .001 · recomputed p < .001
“Z = −12.9, p < .001”
- ConsistentF(1, 832) = 880.8reported p < .001 · recomputed p < .001
“F(1, 832) = 880.8, p < .001”
- ConsistentF(2, 832) = 666.4reported p < .001 · recomputed p < .001
“F(2, 832) = 666.4, p < .001”
2 more recomputed tests
Create a free account to see every test the Stats check recomputed.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Depression and Smoking Cessation: Evidence from a Smoking Cessation Clinic with 1-Year Follow-Up > Abstract > Methods
“Aim 1: N = 3775 patients; 14.3% reported mild and 15.4% moderate/severe baseline depression levels measured using Beck’s Depression Inventory (BDI-II).”
§ Depression and Smoking Cessation: Evidence from a Smoking Cessation Clinic with 1-Year Follow-Up > Methods > Sample
“To address aim 1 (association between baseline level of depression and outcome), patients missing information on age or dependence (n = 16) were excluded, leaving n = 3380 patients for analyses.”
Citations
Cites
The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
HEATHERTON, T. F., KOZLOWSKI, L. T., FRECKER, R. C., & FAGERSTROM, K. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01879.x · Cited by 10,738
Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients
Beck, A. T., Steer, R. A., Ball, R., & Ranieri, W. F. (1996) · Journal of Personality Assessment · doi:10.1207/s15327752jpa6703_13 · Cited by 5,965
Treating Tobacco Use and Dependence: 2008 Update: (566222009-001)
(2009) · PsycEXTRA Dataset · doi:10.1037/e566222009-001 · Cited by 3,046
Outcome criteria in smoking cessation trials: proposal for a common standard
West, R., Hajek, P., Stead, L., & Stapleton, J. (2005) · Addiction · doi:10.1111/j.1360-0443.2004.00995.x · Cited by 1,285 · cited 2×
“Patients lost to follow-up despite multiple attempts at contact (15%) were recorded as not abstinent [30].”
Pharmacological interventions for smoking cessation: an overview and network meta-analysis
Cahill, K., Stevens, S., Perera, R., & Lancaster, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009329.pub2 · Cited by 1,243 · cited 1×
“As in previous findings on effectiveness [31] and efficacy [32], pharmacotherapy use in this clinic mostly predicted higher abstinence than no medication.”
Change in mental health after smoking cessation: systematic review and meta-analysis
Taylor, G., McNeill, A., Girling, A., Farley, A., Lindson-Hawley, N., & Aveyard, P. (2014) · BMJ · doi:10.1136/bmj.g1151 · Cited by 1,039 · cited 3×
“ies found that compared with continuing to smoke, quitting smoking was associated with a significant decrease in depression from baseline to follow-up [9].”
InfluentialDeterminants of Tobacco Use and Renaming the FTND to the Fagerstrom Test for Cigarette Dependence
Fagerstrom, K. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr137 · Cited by 976
Lawrence, D., Hancock, K. J., & Kisely, S. (2013) · BMJ · doi:10.1136/bmj.f2539 · Cited by 819
Michie, S., Wood, C. E., Johnston, M., Abraham, C., Francis, J. J., & Hardeman, W. (2015) · Health Technology Assessment · doi:10.3310/hta19990 · Cited by 680
Outcomes of Nordic mental health systems: life expectancy of patients with mental disorders
Wahlbeck, K., Westman, J., Nordentoft, M., Gissler, M., & Laursen, T. M. (2011) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.085100 · Cited by 623
Research works printed but not linked: 3
- Royal College of Physicians, Royal College of Psychiatrists: smoking and mental health. London: RCP, 2013.
- Fiore MC, Jaen CR, Baker TBea: treating tobacco use and dependence: 2008 update. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service, 2008.
- Cooper J, Borland R, Yong HH, Fotuhi O: The impact of quitting smoking on depressive symptoms: Findings from the International Tobacco Control Four-Country Survey. Addiction. 2016; 111(8):1448-1456. doi: 10.1111/add.13367 . · DOI · Paper page
Cited by
Marx, W., Manger, S. H., Blencowe, M., Murray, G., Ho, F. Y.-Y., Lawn, S., Blumenthal, J. A., Schuch, F., Stubbs, B., Ruusunen, A., et al. (2023) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2022.2112074 · Cited by 179
Omega-3 and omega-6 fatty acid levels in depressive and anxiety disorders
Thesing, C. S., Bot, M., Milaneschi, Y., Giltay, E. J., & Penninx, B. W. J. H. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.10.005 · Cited by 123
Exercise as a therapeutic modality for the prevention and treatment of depression
Blumenthal, J. A., & Rozanski, A. (2023) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2023.02.008 · Cited by 95
Garey, L., Olofsson, H., Garza, T., Rogers, A. H., Kauffman, B. Y., & Zvolensky, M. J. (2020) · Current Addiction Reports · doi:10.1007/s40429-020-00321-z · Cited by 111
Brand, S., Colledge, F., Ludyga, S., Emmenegger, R., Kalak, N., Sadeghi Bahmani, D., Holsboer-Trachsler, E., Pühse, U., & Gerber, M. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.00249 · Cited by 78
Metadata
- Authors
- Stepankova, L., Kralikova, E., Zvolska, K., Pankova, A., Ovesna, P., Blaha, M., & Brose, L. S.
- Affiliations
- Masaryk University (CZ)
- King's College London (GB)
- Corresponding author
- Brose, Leonie S
- Venue
- Annals of Behavioral Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-12-29
- Volume
- 51
- Issue
- 3
- Pages
- 454-463
- ISSN
- 0742-5554 (ISSN-L)
- 0883-6612
- 1532-4796
- PMC
- PMC5440483
- OpenAlex
- W2563836337
- Semantic Scholar
- 7df825b6c6464c3a0b88ee58e341228d12d4ba98
- Cited by
- 78
- References
- 40
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 6 · 2023: 9 · 2022: 10 · 2021: 11 · 2020: 11 · 2019: 10 · 2018: 7 · 2017: 4
- FWCI
- 5.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Annals of Behavioral Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion, cc-by)
- Funders
- Cancer Research UK (C52999/A19748)
- Univerzita Karlova (Prvouk P25/LF1/2)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Keywords
- depression, smoking cessation, smoking abstinence, depression severity, smoking cessation clinics, Beck Depression Inventory-II, follow-up outcomes, tobacco dependence treatment, smoking cessation pharmacotherapy, smoking cessation self-help
- MeSH terms
- Adult, Counseling, Depression, Female, Humans, Male, Middle Aged, Recurrence, Smoking, Cohort Studies, Smoking Cessation, Treatment Outcome, Evidence-Based Practice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Depression and Smoking Cessation: Evidence from a Smoking Cessation Clinic with 1-Year Follow-Up. https://app.cochat.ai/papers/10.1007/s12160-016-9869-6
- The paper
- Stepankova, L., Kralikova, E., Zvolska, K., Pankova, A., Ovesna, P., Blaha, M., & Brose, L. S. (2017). Depression and Smoking Cessation: Evidence from a Smoking Cessation Clinic with 1-Year Follow-Up. Annals of Behavioral Medicine. https://doi.org/10.1007/s12160-016-9869-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.